References
- http://quincybioscience.com/about/
- Grosskreutz J, van den Bosch L, Keller B. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47: 165–74.
- van den Bosch L, Schwaller B, Vleminckx V, Meijers B, Stork S, Ruehlicke T, . Protective effect of parvalbumin on excitotoxic motor neuron death. Exp Neurol. 2002;174:150–61.
- Dekkers J, Bayley P, Dick J, Schwaller B, Berchtold M, Greensmith L. Over-expression of parvalbumin in transgenc mice rescues motor neurons from injury-induced death. Neuroscience. 2004;123:459–66.
- http://quincybioscience.com/files/Neuroscience2009.pdf
- Miller RG, Smith SA, Murphy JR, Brinkmann JR, Graves J, Mendoza M, . A clinical trial of verapamil in amyotrophic lateral sclerosis. Muscle Nerve. 1996;19:511–5.
- Miller RG, Shepherd R, Dao H, Khramstov A, Mendoza M, Graves J, Smith S. Controlled trial of nimodipine in amyotrophic lateral sclerosis. Neuromuscul Disord. 1996;6: 101–14.
- Payne A. Experimental regimen targeting the ependymal slows disease progression in four patients with amyotrophic lateral sclerosis. Medical Hypothesis. 2009;72:548–50.
- http://illnessisoptional.com/store/discount-professional-supplements-store/books-cd/memory-enhancement/quincy-bioscience/prevagen-professional-strength-40mg-30-capsules.html.